Re:UBiome received $83M in Series C financing
by refurb on Friday September 21, 2018 @01:45PM
(#18041367)
You summed up my concerns better than I could.
I remember when uBiome launched out of UCSF. I remember thinking “ok, they’ll sequence your microbiome and then...what exactly?”
Re:UBiome received $83M in Series C financing
by funfunfun on Friday September 21, 2018 @01:54PM
(#18041438)
I gave my data files from uBiome to a microbiologist and was told 'these data are too low in quality to analyze'
Re:UBiome received $83M in Series C financing
by refurb on Friday September 21, 2018 @02:47PM
(#18041791)
Yikes.
To be honest, the microbiome space is interesting and may hold promise for therapeutics - and maybe uBiome will be a leader in it.
But there is a very good chance that nothing will come of this whatsoever.
Re:UBiome received $83M in Series C financing
by Nzen on Friday September 21, 2018 @02:14PM
(#18041567)
a fantasy: I get intestinal distress from food/water while on vacation. I take antibiotics to clear the problem. At a later date, I have a fecal transplant [0]. It couldn't be mine, because that was the site of the problem. Instead, I order a culture that matches my previous microbiome distribution.
[0] https://arstechnica.com/science/2018/09/probiotics-if-you-do...
Re:UBiome received $83M in Series C financing
by refurb on Friday September 21, 2018 @02:44PM
(#18041766)
I think to do this, you'd need data points that don't yet exist: if your microbiome changes from antibiotic use, will you suffer health effects (beyond infection with a disease causing bacteria like C. difficle)?
- There are no actions to be taken based on microbiome data
- There's no government oversight to the quality of their sequencing or bioinformatics
- The reviews don't indicate the kits are useful https://www.highya.com/ubiome-reviews
Maybe a good comparison would be if Theranos gave you a 'subjective wellness score' instead of standard test results